TasP works by reducing the amount of HIV in the blood and other bodily fluids to undetectable levels. When the viral load is undetectable, the risk of HIV transmission through sexual contact, needle sharing, and from mother to child during birth or breastfeeding is significantly reduced. This concept is often summarized by the phrase "Undetectable = Untransmittable" (U=U).
